Medical Writing Intern
Alexion Pharmaceuticals, Inc.
Summary
Alexion- AstraZeneca Rare Disease is seeking a Medical Writing Intern to support the Medical Writing organization at its Boston-Seaport, Massachusetts location. The intern will contribute to clinical-regulatory documents, interpret complex scientific data, and support AI-based Medical Writing initiatives that improve content development and workflow efficiency.
Job description
Key Responsibilities
- Co-author clinical-regulatory documents within a program, ensuring relevant regulatory, technical, and quality standards are achieved.
- Apply relevant processes and best practices to the development of clinical-regulatory documents.
- Contribute to AI-based Medical Writing initiatives that facilitate the automation of content or tasks for process improvement.
- Interpret complex clinical data and information and condense it into clear, concise, and accurate messages that address information requirements.
Required Qualifications
- Currently pursuing a PhD or a non-MBA Master’s Degree in Public Health, Pharmaceutical Science, Regulatory Science, Biological Science.
- Meeting the applicable graduation timeline requirements with an anticipated graduation date set for after August 2027.
- US Work Authorization is required at time of application. Applicants must have work authorization that does not require future sponsorship.
- This role will not be granting OPT support.
- Advanced proficiency with Microsoft Word functions.
- Strong writing and editing ability, including the ability to summarize data.
- Experience with electronic document management systems is a plus.
- Experience with AI-assisted drafting and summarization tools is a plus.
- Scientific or technical understanding.
- Critical-thinking and analytical skills.
- Strong communication and presentation skills.
- Ability to report on site to Boston-Seaport, MA 3 days a week. This role will not provide relocation assistance.
Requirements
- Currently pursuing a PhD or a non-MBA Master’s Degree in Public Health, Pharmaceutical Science, Regulatory Science, Biological Science
- Anticipated graduation date after August 2027
- US Work Authorization required at time of application; must not require future sponsorship
- This role will not be granting OPT support
- Advanced proficiency with Microsoft Word functions
- Strong writing and editing ability, including the ability to summarize data
- Experience with electronic document management systems is a plus
- Experience with AI-assisted drafting and summarization tools is a plus
- Scientific or technical understanding
- Critical-thinking and analytical skills
- Strong communication and presentation skills
- Ability to report on site to Boston-Seaport, MA 3 days a week
Company overview
Alexion Pharmaceuticals, Inc., now a subsidiary of AstraZeneca, is a leading pharmaceutical company specializing in the development and commercialization of orphan drugs for rare diseases. Founded in 1992 and headquartered in Boston, Massachusetts, the company has established itself as a pioneer in treating ultra-rare disorders through innovative biologic therapies. Alexion's flagship products include Soliris (eculizumab) and Ultomiris (ravulizumab), both used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The company's portfolio also features Strensiq (asfotase alfa) for hypophosphatasia, Kanuma (sebelipase alfa) for lysosomal acid lipase deficiency, and Andexxa (andexanet alfa) for reversing anticoagulation effects. With approximately 2,525 employees and annual revenues exceeding $6 billion, Alexion operates globally, focusing on life-transforming treatments for patients with severe and life-threatening rare diseases. The company's acquisition by AstraZeneca in 2021 has further strengthened its position in the rare disease therapeutic area, combining Alexion's specialized expertise with AstraZeneca's global reach and research capabilities.